Pharmafile Logo
Pharmafocus logo
Advanced Search
rampd-charnwood

AstraZeneca’s UK research centre prepares to close

November 18, 2011
Research and Development AstraZeneca, Charnwood

AstraZeneca has thrown more light on the pending closure of its UK R&D site in Charnwood, saying that 90% of …

News

First stem cell trial halted due to costs

November 18, 2011
Research and Development Geron, Stem cells

One of the world’s first stem cell trials has been put on hold due to ‘uncertain economic conditions’.Geron, the firm undertaking …

News

Bayer forecasts €11 billion growth in Asia

November 17, 2011
Bayer, China, emerging markets

Bayer is expecting sales in Asia to grow by €11 billion over the next four years, with over half of …

News

Industry supports bid to revitalise antibiotic research

November 17, 2011
Research and Development, Sales and Marketing EFPIA, Europe, IMI, antibiotic

The European Commission and the European pharma industry have unveiled plans to accelerate the discovery and development of new antibiotics. …

News

Jeremy Poland

November 17, 2011
Sales and Marketing MSI Consultancy

Pharmaceutical consultancy firm The MSI Consultancy has appointed Jeremy Poland as a Graduate Analyst in its Marketing Sciences division. Jeremy …

Appointment

NICE will not back Eisai’s Halaven

November 17, 2011
Medical Communications, Sales and Marketing Eisai, Halaven, NICE, breast cancer

NICE has not recommended Eisai’s novel breast cancer drug Halaven due to concerns over its safety and cost.In draft guidance …

News
life_healthcare_jpg

Life Healthcare makes four new appointments

November 16, 2011
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Life healthcare communications

Life Healthcare Communications has made four new appointments, adding to its client service, creative and digital teams. Vicki Marsh joins …

Appointment

GSK diabetes drug fails head-to-head against Victoza

November 16, 2011
Sales and Marketing GLP-1, Victoza, albiglutide, diabetes

GlaxoSmithKline’s long-acting diabetes drug albiglutide has failed in a head-to-head trial against Novo Nordisk’s Victoza. Albiglutide is an injectable glucagon-like …

News

Multaq raises risk of death in permanent AF patients

November 16, 2011
Sales and Marketing AF, Multaq, Sanofi

More bad news for Sanofi’s Multaq as new data shows the drug doubles the risk of death in people with …

News

Is global consistency in GCP interpretation an achievable goal?

November 16, 2011
Research and Development

The potential benefits of standardisation in the conduct of an increasingly global clinical research effort are enormous. The promise of …

Feature
Thought Leadership

Quicker and slicker: new initiatives to improve clinical trial delivery

November 16, 2011
Research and Development

Faster study set-up times, reduced bureaucracy and timely patient recruitment – these things are central to the success of commercial …

Feature
Thought Leadership

Infectious diseases versus clinical researchers. Who is winning?

November 16, 2011
Research and Development

They were running hand in hand, and the Queen went so fast that it was all she could do to …

Feature
Thought Leadership

Full service CROs: a cost-effective option for global therapeutically focused clinical development expertise

November 16, 2011
Research and Development

Skyrocketing clinical development costs are bad news for everyone, from pharmaceutical companies to patients. That’s why it’s crucial we find …

Feature
Thought Leadership

Emerging markets: comparing India and China as the future R&D hubs for the pharmaceutical industry

November 16, 2011
Research and Development

The pharmaceutical industry is expanding worldwide. For the last few years, the emerging markets that offer the dynamics of growth …

Feature
Thought Leadership
Boehringer pic

Boehringer invests $65 million in early R&D centre

November 16, 2011
Research and Development, Sales and Marketing Boehringer Ingelheim

Boehringer Ingelheim is investing $65 million for an early-stage research and development centre in the US. The new 72,000 sq.ft. …

News

Pharmacovigilance in the EU – recent and future changes

November 15, 2011
Research and Development

Changes to both post-marketing and clinical trial requirements

Feature
Thought Leadership
Boehringer Facebook image

Boehringer developing Facebook game

November 15, 2011
Medical Communications Boehringer Ingelheim, Facebook

Boehringer Ingelheim is developing a new Facebook civilisation game in the hopes of helping the public understand the difficulty involved …

News

The roles and responsibilities of an EEA qualified person for pharmacovigilance (QPPV)

November 15, 2011
Research and Development

The roles and responsibilities of an EEA Qualified Person for Pharmacovigilance are based on the current Directive 2001/83/EC and Vol …

Feature
Thought Leadership

Merck’s vorapaxar fails in late-stage trial

November 15, 2011
ACS, Brilinta, Efient, Merck, Plavix, antiplatelet, vorapaxar

Merck’s novel blood thinner vorapaxar has failed to meet its primary endpoint in a late-stage study.The TRACER trial compared vorapaxar …

News

UCB will double staff at Swiss bioproduction facility

November 15, 2011
Manufacturing and Production UCB, manufacturing

Belgian pharmaceutical company UCB showcased its new bioproduction facility in Bulle, Switzerland, yesterday, saying that the workforce there looks set …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026